HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Shares GMP Guidelines To Boost Compliance, Not Suggest DSHEA Reform

This article was originally published in The Tan Sheet

Executive Summary

Sharing the guidelines, along with AHPA's good agricultural practices, across the industry should help firms comply with FDA's GMPs required under DSHEA, says GNC CEO Mike Archbold. "I would encourage all, including legislators, to take a look at what we are doing," he says.

You may also be interested in...



CVS Standards: Another Step In Supplement Industry Transparency Evolution

CVS Pharmacy is developing standards, including third-party tests, for vitamins and supplements sold in its stores. Targeted for implementation by 2019, the standards are part of a health care-focused effort in which the firm will expand its lineup of vitamins and supplements.

NPA, Retailers Tackle Accountability: Health & Wellness Industry News Roundup

NPA, retailers tackle farm-to-shelf accountability; Probiotic best practices from CRN, IPA; Born Wild to incubate food, beverage brands; and more news in brief.

State AGs Out Of Their Bailiwick Testing Supplement Ingredient Identities

State AGs can determine whether a supplement label makes an unsubstantiated claim, their previous litigation target, but they aren't qualified to test ingredient identity, says Doreen Manchester in a FDLI presentation on state agencies' enforcement.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel